Silexion Therapeutics Files Proxy Statement
Ticker: SLXNW · Form: DEFA14A · Filed: Jul 7, 2025 · CIK: 2022416
Sentiment: neutral
Topics: proxy-statement, corporate-governance, name-change
TL;DR
Silexion (fka Biomotion) filed proxy docs July 7. Standard corp stuff.
AI Summary
Silexion Therapeutics Corp filed a Definitive Additional Materials proxy statement on July 7, 2025. The company, formerly known as Biomotion Sciences until May 6, 2024, is incorporated in E9 and has its fiscal year end on December 31. Its business and mailing address are both located at 12 Abba Hillel Road, Ramat Gan, L3, 5250606.
Why It Matters
This filing indicates ongoing corporate activities and communications with shareholders, which is standard for publicly traded companies. It may contain important information regarding upcoming shareholder votes or corporate governance matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not appear to contain significant new financial information or strategic shifts that would immediately impact risk.
Key Players & Entities
- Silexion Therapeutics Corp (company) — Registrant
- Biomotion Sciences (company) — Former company name
- 0001178913-25-002313 (filing_id) — Accession Number
- 20250707 (date) — Filing Date
- 12 ABBA HILLEL ROAD (address) — Business Address
- RAMAT GAN (city) — Business Address City
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement filed by Silexion Therapeutics Corp on July 7, 2025, pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When did Silexion Therapeutics Corp change its name?
Silexion Therapeutics Corp was formerly known as Biomotion Sciences, with the name change occurring on May 6, 2024.
What is Silexion Therapeutics Corp's fiscal year end?
The company's fiscal year ends on December 31.
Where is Silexion Therapeutics Corp located?
The company's business and mailing address is 12 Abba Hillel Road, Ramat Gan, L3, 5250606.
Is there a fee associated with this filing?
No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on July 7, 2025 regarding Silexion Therapeutics Corp (SLXNW).